← Back to Screener
ENvue Medical, Inc. Common Stock (FEED)
Price$1.36
Favorite Metrics
Price vs S&P 500 (26W)-82.26%
Price vs S&P 500 (4W)-2.54%
Market Capitalization$5.59M
All Metrics
Book Value / Share (Quarterly)$51.41
Price vs S&P 500 (YTD)-38.56%
10-Day Avg Trading Volume0.25M
EPS (Annual)$-137.32
ROI (Annual)-590.91%
Gross Margin (Annual)58.95%
Cash / Share (Quarterly)$5.12
ROA (Last FY)-102.09%
Cash Flow / Share (Annual)$-66.48
P/B Ratio0.14x
P/B Ratio (Quarterly)0.06x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-34.44x
EPS Incl Extra (Annual)$-137.32
Current Ratio (Annual)1.22x
Quick Ratio (Quarterly)0.64x
3-Month Avg Trading Volume8.65M
52-Week Price Return-97.89%
Tangible BV / Share (Quarterly)$44.40
P/S Ratio (Annual)2.18x
Asset Turnover (Annual)0.70x
52-Week High$75.48
EPS Excl Extra (Annual)$-137.32
26-Week Price Return-75.37%
Quick Ratio (Annual)0.37x
13-Week Price Return3.42%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.05x
Enterprise Value$3.533
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-144.10%
Cash / Share (Annual)$19.85
3-Month Return Std Dev328.82%
ROE (Last FY)-590.91%
EPS Basic Excl Extra (Annual)$-137.32
Total Debt / Equity (Quarterly)0.05x
Revenue / Share (Annual)$94.81
Price vs S&P 500 (52W)-132.52%
Year-to-Date Return-34.63%
5-Day Price Return-3.82%
EPS Normalized (Annual)$-137.32
Net Profit Margin (Annual)-144.84%
Month-to-Date Return-36.55%
EBITD / Share (Annual)$-132.73
Operating Margin (Annual)-140.03%
P/TBV (Quarterly)0.07x
P/B Ratio (Annual)2.94x
Book Value / Share (Annual)$16.55
Price vs S&P 500 (13W)1.04%
Beta1.81x
52-Week Low$0.99
Analyst Recommendations
Sep 2021
Oct 2021
Nov 2021
Dec 2021
4.14
4.14
4.14
4.14
Industry Peers — Orthopedic & Prosthetic Devices(26)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
FEEDENvue Medical, Inc. Common Stock | — | — | — | — | $1.36 |
ISRGIntuitive Surgical Inc. | 16.19x | 18.22% | 66.00% | 29.27% | $453.37 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $80.13 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $219.45 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $92.69 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $194.85 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $32.84 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $171.95 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $64.06 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $23.73 |
CDRECadre Holdings, Inc. | 2.14x | 8.57% | 42.54% | 11.04% | $29.45 |
About
ENvue Medical develops medical devices that provide real-time visual guidance for safe and accurate feeding tube placement in hospitals and ICUs. Its ENvue system uses smart sensors and body mapping technology to reduce complications and confirm proper positioning. The company is expanding into vascular access applications.